We are pleased to announce the results of our latest  #study, conducted in collaboration with HELLESCC | Hellenic Society of Crohn Disease And Ulcerative Colitis Patients.

Our findings highlight a critical insight: a significant proportion of patients with inflammatory bowel disease (IBD) continue to experience a high disease burden despite biological therapy.

🎯 Key Findings:
🟢 Despite biologic treatments, many IBD patients in Greece still face:
🔸 Poor quality of life (QoL)
🔸 Increased work and activity impairment

📊 48% of patients reported moderate to severe depressive symptoms, revealing the considerable psychological impact of IBD.

⚠️ 30% experienced severe impairment in work and daily activities.
💬 4 in 10 patients expressed dissatisfaction with their current treatment.

💡 It’s time to shift our focus toward holistic care, integrating psychological support and striving for real improvements in the daily lives of IBD patients.

Read more at the following links:

1) ygeia mou. 2) the daily health. 3) iatronet 4) in.gr  5)health report